Tetravalent multispecific antibodies
US-2026049160-A1 · Feb 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Molhoj Michael patents
Molhoj Michael is listed as an inventor on 79 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Molhoj Michael |
| Total patents | 79 |
| First publication | Nov 5, 2015 |
| Latest publication | Feb 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Bispecific t cell activating antigen binding molecules
US-2026022172-A1 · Jan 22, 2026 · US
Antibody that binds to VEGF-A and ANG2 and methods of use
US-12522653-B2 · Jan 13, 2026 · US
Humanized anti-human cd19 antibodies and methods of use
US-2025376523-A1 · Dec 11, 2025 · US
Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of use
US-2025297025-A1 · Sep 25, 2025 · US
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies
US-12358997-B1 · Jul 15, 2025 · US
Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of use
US-2025223372-A1 · Jul 10, 2025 · US
Humanized anti-Tau(PS422) antibodies and methods of use
US-12297263-B2 · May 13, 2025 · US
Direct affinity measurement of human IgG1 binding multimeric antigens
US-12287335-B2 · Apr 29, 2025 · US
Humanized anti-human CD19 antibodies and methods of use
US-12215152-B2 · Feb 4, 2025 · US
Recent patents
Latest publications not already listed above.
Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use
US-2024317879-A1 · Sep 26, 2024 · US
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
US-12030952-B2 · Jul 9, 2024 · US
Bispecific t cell activating antigen binding molecules
US-2024141044-A1 · May 2, 2024 · US
Method for determining the in vivo interaction mode
US-11958912-B2 · Apr 16, 2024 · US
Bispecific antibodies against CD3EPSILON and ROR1
US-11952421-B2 · Apr 9, 2024 · US
Antibody that binds to vegf-a and ang2 and methods of use
US-2023374119-A1 · Nov 23, 2023 · US
Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of use
US-2023365702-A1 · Nov 16, 2023 · US
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
US-11787868-B2 · Oct 17, 2023 · US
Bispecific t cell activating antigen binding molecules
US-2023287118-A1 · Sep 14, 2023 · US
Humanized anti-tau(ps422) antibodies and methods of use
US-2023265177-A1 · Aug 24, 2023 · US
Antibody that binds to VEGF-A and ANG2 and methods of use
US-11732036-B2 · Aug 22, 2023 · US
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
US-11603411-B2 · Mar 14, 2023 · US
Humanized anti-Tau(pS422) antibodies and methods of use
US-11572404-B2 · Feb 7, 2023 · US
Bispecific t cell activating antigen binding molecules
US-2022403027-A1 · Dec 22, 2022 · US
Multispecific antibodies
US-2022363771-A1 · Nov 17, 2022 · US
Method for detecting multispecific antibody light chain mispairing
US-11486882-B2 · Nov 1, 2022 · US
Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use
US-2022306761-A1 · Sep 29, 2022 · US
Humanized anti-human cd19 antibodies and methods of use
US-2022204616-A1 · Jun 30, 2022 · US
Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of use
US-2022144963-A9 · May 12, 2022 · US
Humanized anti-human CD19 antibodies and methods of use
US-11286300-B2 · Mar 29, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 74 |
| Amgen Res Munich Gmbh | 4 |
| Takeda Gmbh | 4 |
| Hoffman La Rocher Inc | 1 |
| Bristol Myers Squibb Co | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 64 |
| C07K2317/92 | 61 |
| C07K2317/55 | 57 |
| A61K2039/505 | 50 |
| A61P35/00 | 41 |